A Pragmatic INitiative for LDL-C Management by a CLinical Pharmacist-Led Team Among Atherosclerotic CardiovascUlar DisEase Patients

Part of paid clinical trials in Salt Lake City, Utah.

Sponsor
Intermountain Health Care, Inc.
Study ID
NCT06571162
Status
Recruiting
Apply to this trial

Conditions

  • Atherosclerotic Cardiovascular Disease

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Clinical Pharmacy Team — OTHER
    Patients will receive targeted care of their LDL-C through a pharmacist-driven management program.
  • Usual Care — OTHER
    Patient will receive usual care for their LDL-C management.

Study Details

Patients who had an ASCVD event at an Intermountain hospital will be screened for eligibility to be randomized. Subjects who meet eligibility criteria will be randomized 1:1 to receive targeted care of their LDL-C through a pharmacist-driven management program or not. Patients may opt-out of receiving LDL-C management by the pharmacy team at any time. The purpose of this program is to increase the proportion of patients who achieve guideline-based recommendations of LDL-C levels of \<70 mg/dL by increasing statin and/or LLT adherence and LDL-C testing. Data collection as part of the study will continue until the last person randomized has had 1-year of follow-up.

Key Dates

Start date
Jan 30, 2025
Status verified
Apr 2025
Primary completion
Jan 31, 2028
Completion
Sep 30, 2028

Study Design

Enrollment
400 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH

Arms

  • Active Comparator: Usual Care
    Patients will receive usual care for their LDL-C management.
  • Experimental: Clinical Pharmacy Team
    Patients will receive targeted care of their LDL-C through a pharmacist-driven management program.

Primary Outcome Measure

Proportion of patients who achieve an LDL-C <70 mg/dL by 1-year. [ Time Frame: 1 year ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Intermountain Healthcare Hospitals and ClinicsSalt Lake CityUtah84107
Kirk U Knowlton, MD
[email protected]
801.507.4701
Heidi T May, PhD, MSPH
[email protected]
801-507-4700
Kirk U Knowlton, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Salt Lake City, UT

By research site
Intermountain Healthcare Hospitals and Clinics· Salt Lake City, UT

Related Studies